We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
New horizons for treatment of ANCA-associated vasculitides.
- Authors
Guillevin, Loïc; Mahr, Alfred
- Abstract
The article presents insights on the study "Recommendations for the use of rituximab in anti-neutropil cytoplasm antibody (ANCA)-associated vasculitis." It cites the challenge facing caregivers in deciding about the incorporation of rituximab into defined therapy algorithms. Two clinical trials have shown the effectiveness and safety of rituximab as conventional immunosuppressive therapy in controlling granulomatosis.
- Subjects
THERAPEUTIC use of glucocorticoids; RITUXIMAB; VASCULITIS; GRANULOMATOSIS with polyangiitis; SEVERITY of illness index; PATIENT selection; CYCLOPHOSPHAMIDE
- Publication
Rheumatology, 2012, Vol 51, Issue 4, p583
- ISSN
1462-0324
- Publication type
Editorial
- DOI
10.1093/rheumatology/ker187